MeiraGTx Holdings plc MGTX NASDAQ

MeiraGTx Holdings plc (MGTX) reported total assets of $244.43M and total liabilities of $250.22M for fiscal year 2025, resulting in total equity of $-5.79M.

The company held $65.93M in cash and short-term investments. Total debt stood at $88.69M, with net debt of $22.76M. The Debt-to-Equity (D/E) ratio was -15.31 (conservative).

Current ratio is 0.75, which may signal tight short-term liquidity. Interest coverage is -8.7x (weak).

Criteria supported by this page:

• HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (56/100) — Total assets $244.43M and equity $-5.79M support the company's competitive scale
• VALUE (100/100) — Debt-to-Equity -15.31 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 46/100 with 2/7 criteria passed.

RYTM

Rhythm Pharmaceuticals, Inc.

$87.28

+0.54%

ERAS

Erasca, Inc.

$17.85

+9.44%

EWTX

Edgewise Therapeutics, Inc.

$33.16

-2.01%

IDYA

IDEAYA Biosciences, Inc.

$32.35

-1.43%

ANAB

AnaptysBio, Inc.

$70.22

+2.17%

NUVB

Nuvation Bio Inc.

$4.85

+3.19%

QURE

uniQure N.V.

$17.09

-4.63%

ETON

Eton Pharmaceuticals, Inc.

$27.12

+4.11%